Laila Samady-Mustad
Director of Business Development
Laila is responsible for corporate business development strategy at CNM Estates. She is also an advisor for the company’s marketing and communications strategy, and plays an integral role in our company management. She initially joined the company in 2016, as Director of Community Engagement.
Laila has 20 years’ experience both academically and in the pharmaceutical, medical and biotechnology industry in biological sciences, cancer research and therapeutics in the UK, France and in the US, with expertise in medical affairs, partnerships, business development and capital raise strategy. Based in London, she has been working as strategic advisor, Vice-President, Business Development for two companies, Covanos Inc., a development stage medical technology company focusing on computational vascular diagnostics and Global Genomics Group (G3 Therapeutics), a biotechnology company with expertise in life sciences, artificial intelligence and data computing.
With a PhD in Molecular Pathology and Immunology from University College London (UCL), Laila’s work at UCL led to the development of patents and a spin out company, BioVex which was acquired by Amgen in 2011 for $1B. While at Boehringer Ingelheim Pharmaceuticals, she served in increasingly senior roles initially in cardiovascular medical affairs leading to a global strategic role in oncology medical affairs and Global Trial Alliance Manager. Prior to her PhD, Laila obtained a BSc in Biochemistry at Trinity College, Hartford, CT and MSc in Molecular and Cell Biology from Institut Pasteur, Paris.
Laila lives in London with her husband and 7 year old son, and enjoys as a hobby to exercise and spend time with her family boating on the Solent.
laila.samady-mustad@cnmestates.com